Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 227

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial

Open access
Myles, Paul S, Leslie, Kate, Chan, Matthew T V, Forbes, Andrew, Peyton, Philip J, Paech, Michael J, Beattie, W Scott, Sessler, Daniel I, Devereaux, P J, Silbert, Brendan, Schricker, Thomas, Wallace, Sophie·2014·The Lancet

Abstract

BACKGROUND Nitrous oxide is commonly used in general anaesthesia but concerns exist that it might increase perioperative cardiovascular risk. We aimed to gather evidence to establish whether nitrous oxide affects perioperative cardiovascular risk. METHODS We did an international, randomised, assessor-blinded trial in patients aged at least 45 years with known or suspected coronary artery disease having major non-cardiac surgery. Patients were randomly assigned via automated telephone service, stratified by site, to receive a general anaesthetic with or without nitrous oxide. Attending anaesthetists were aware of patients' group assignments, but patients and assessors were not. The primary outcome measure was a composite of death and cardiovascular complications (non-fatal myocardial infarction, stroke, pulmonary embolism, or cardiac arrest) within 30 days of surgery. Our modified intention-to-treat population included all patients randomly assigned to groups and undergoing induction of general anaesthesia for surgery. This trial is registered at ClinicalTrials.gov, number NCT00430989. FINDINGS Of 10,102 eligible patients, we enrolled 7112 patients between May 30, 2008, and Sept 28, 2013. 3543 were assigned to receive nitrous oxide and 3569 were assigned not to receive nitrous oxide. 3483 patients receiving nitrous oxide and 3509 not receiving nitrous oxide were assessed for the primary outcome. The primary outcome occurred in 283 (8%) patients receiving nitrous oxide and in 296 (8%) patients not receiving nitrous oxide (relative risk 0·96, 95% CI 0·83–1·12; p=0·64). Surgical site infection occurred in 321 (9%) patients assigned to nitrous oxide, and in 311 (9%) patients in the no-nitrous oxide group (p=0·61), and severe nausea and vomiting occurred in 506 patients (15%) assigned to nitrous oxide and 378 patients (11%) not assigned to nitrous oxide (p<0·0001). INTERPRETATION Our findings support the safety profile of nitrous oxide use in major non-cardiac surgery. Nitrous oxide did not increase the risk of death and cardiovascular complications or surgical-site infection, the emetogenic effect of nitrous oxide can be controlled with antiemetic prophylaxis, and a desired effect of reduced volatile agent use was shown. FUNDING Australian National Health and Medical Research Council; Australian and New Zealand College of Anaesthetists; Heart and Stroke Foundation of Quebec, Heart and Stroke Foundation of Ontario, Canada; General Research Fund of the Research Grant Council, Hong Kong Special Administrative Region, China.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(14)60893-x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 31

  1. Devereaux, 2005, Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk, CMAJ, 173, 627, 10.1503/cmaj.050011 · DOI · Paper page
  2. Mangano, 1995, Preoperative assessment of patients with known or suspected coronary disease, N Engl J Med, 333, 1750, 10.1056/NEJM199512283332607 · DOI
  3. Grocott, 2012, Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery, Cochrane Database Syst Rev, 11, 10.1002/14651858.CD004082.pub5 · DOI
  4. Lison, 2011, Postoperative changes in procoagulant factors after major surgery, Blood Coagul Fibrinolysis, 22, 190, 10.1097/MBC.0b013e328343f7be · doi:10.1097/mbc.0b013e328343f7be
  5. Badner, 2000, Nitrous oxide-induced increased homocysteine concentrations are associated with increased postoperative myocardial ischemia in patients undergoing carotid endarterectomy, Anesth Analg, 91, 1073
  6. Myles, 2008, Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function, Anesthesiology, 109, 657, 10.1097/ALN.0b013e31818629db · DOI
  7. Ermens, 1991, Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine, Clin Pharmacol Ther, 49, 385, 10.1038/clpt.1991.45 · DOI
  8. Nunn, 1987, Clinical aspects of the interaction between nitrous oxide and vitamin B12, Br J Anaesth, 59, 3, 10.1093/bja/59.1.3 · DOI · Paper page
  9. Albert, 2008, Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial, JAMA, 299, 2027, 10.1001/jama.299.17.2027 · DOI · Paper page
  10. Wald, 2002, Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis, BMJ, 325, 1202, 10.1136/bmj.325.7374.1202 · DOI · Paper page
  11. Huang, 2012, Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality, Clin Nutr, 31, 448, 10.1016/j.clnu.2011.01.003 · DOI
  12. Clarke, 2010, Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals, Arch Intern Med, 170, 1622, 10.1001/archinternmed.2010.348 · DOI · Paper page
  13. Myles, 2007, Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial, Anesthesiology, 107, 221, 10.1097/01.anes.0000270723.30772.da · DOI · Paper page
  14. Leslie, 2011, Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial, Anesth Analg, 112, 387, 10.1213/ANE.0b013e3181f7e2c4 · DOI
  15. Imberger, 2014, Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta-analysis and trial sequential analysis, Br J Anaesth, 112, 410, 10.1093/bja/aet416 · DOI
  16. Myles, 2009, Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) trial: rationale and design, Am Heart J, 157, 488, 10.1016/j.ahj.2008.11.015 · DOI
  17. Kurz, 1996, Perioperative normothermia to reduce the incidence of surgical wound infection and shorten hospitalization, N Engl J Med, 334, 1209, 10.1056/NEJM199605093341901 · DOI · Paper page
  18. Leonardi, 2013, Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review, Eur Heart J, 34, 894, 10.1093/eurheartj/eht003 · DOI
  19. Myles, 1999, Development and psychometric testing of a quality of recovery score after general anesthesia and surgery in adults, Anesth Analg, 88, 83, 10.1213/00000539-199901000-00016 · DOI · Paper page
  20. Horan, 2008, CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting, Am J Infect Control, 36, 309, 10.1016/j.ajic.2008.03.002 · DOI · Paper page
  21. Gan, 2014, Consensus guidelines for the management of postoperative nausea and vomiting, Anesth Analg, 118, 85, 10.1213/ANE.0000000000000002 · DOI · Paper page
  22. Qadan, 2009, Perioperative supplemental oxygen therapy and surgical site infection: a meta-analysis of randomized controlled trials, Arch Surg, 144, 359, 10.1001/archsurg.2009.1 · DOI · Paper page
  23. Meyhoff, 2009, Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial, JAMA, 302, 1543, 10.1001/jama.2009.1452 · DOI · Paper page
  24. Nagele, 2013, Influence of nitrous oxide anesthesia, B-vitamins, and MTHFR gene polymorphisms on perioperative cardiac events: the vitamins in nitrous oxide (VINO) randomized trial, Anesthesiology, 119, 19, 10.1097/ALN.0b013e31829761e3 · DOI
  25. Turan, 2013, The association between nitrous oxide and postoperative mortality and morbidity after noncardiac surgery, Anesth Analg, 116, 1026, 10.1213/ANE.0b013e31824590a5 · DOI
  26. Leslie, 2013, Nitrous oxide and serious morbidity and mortality in the POISE trial, Anesth Analg, 116, 1034, 10.1213/ANE.0b013e318270014a · DOI
  27. Chen, 2013, Leukocyte DNA damage and wound infection after nitrous oxide administration: a randomized controlled trial, Anesthesiology, 118, 1322, 10.1097/ALN.0b013e31829107b8 · DOI
  28. Fleischmann, 2005, Nitrous oxide and risk of surgical wound infection: a randomised trial, Lancet, 366, 1101, 10.1016/S0140-6736(05)67422-3 · DOI
  29. Bistulfi, 2010, Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells, BMC Biol, 8, 6, 10.1186/1741-7007-8-6 · DOI
  30. Tolg, 2011, Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells, Lab Invest, 91, 825, 10.1038/labinvest.2010.197 · DOI
  31. Chan, 2011, Chronic postsurgical pain after nitrous oxide anesthesia, Pain, 152, 2514, 10.1016/j.pain.2011.07.015 · DOI

Cited by

See all 227

Metadata

Authors
Myles, P. S., Leslie, K., Chan, M. T. V., Forbes, A., Peyton, P. J., Paech, M. J., Beattie, W. S., Sessler, D. I., Devereaux, P. J., Silbert, B., Schricker, T., & Wallace, S.
Venue
The Lancet
Publisher
Elsevier BV
Published
2014-10
Volume
384
Issue
9952
Pages
1446-1454
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2158835803
Cited by
227
References
5
FWCI
17.69
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Australian National Health and Medical Research Council (NHMRC, ID 436677)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial. https://app.cochat.ai/papers/10.1016/s0140-6736(14)60893-x
The paper
Myles, P. S., Leslie, K., Chan, M. T. V., Forbes, A., Peyton, P. J., Paech, M. J., Beattie, W. S., Sessler, D. I., Devereaux, P. J., Silbert, B., Schricker, T., & Wallace, S. (2014). The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial. The Lancet. https://doi.org/10.1016/s0140-6736(14)60893-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.